Advertisement

Health


Australia's top 20 cannabis companies

Australia's top 20 cannabis companies

Whether it’s a “gold rush” to secure registration...

Femma: the healthtech helping women access specialist care

Femma: the healthtech helping women access specialist care

Passionate about providing access to quality healthcare, Dr Emma Re...

Integral Diagnostics bolsters clinic presence in QLD with $37.5 million purchase of Exact Radiology

Integral Diagnostics bolsters clinic presence in QLD with $37.5 million purchase of Exact Radiology

Almost three months after buying nine clinics across Southeast Quee...

Cochlear to acquire loss-making Oticon Medical for $170 million

Cochlear to acquire loss-making Oticon Medical for $170 million

Hearing implant maker Cochlear (ASX: COH) is sounding out global co...

Firebrick Pharma kicks off Phase 2 of COVID-19 nasal spray clinical trial

Firebrick Pharma kicks off Phase 2 of COVID-19 nasal spray clinical trial

The second phase of a clinical trial investigating a nasal spray ma...

Advertisement
Advertisement
Advertisement
Are 3D-printed COVID tests the tip of the iceberg for Australian medical device manufacturing?

Are 3D-printed COVID tests the tip of the iceberg for Australian medical device manufacturing?

Australia's high labour costs have traditionally made it toug...

FDA rejuvenates Avita Medical burns treatment

FDA rejuvenates Avita Medical burns treatment

Avita Medical Inc. (ASX: AVH) has received a big shot in the arm ...

Cogstate into gear as partners achieve breakthrough FDA approval for Alzheimer's drug

Cogstate into gear as partners achieve breakthrough FDA approval for Alzheimer's drug

Investors in Melbourne-based digital cognitive assessment technol...

ANTG enters partnership with hopes to export first medicinal cannabis flower to NZ

ANTG enters partnership with hopes to export first medicinal cannabis flower to NZ

Earlier this year a Byron Bay-based company achieved a milestone ...

Could new findings put Mesoblast back in the COVID treatment race?

Could new findings put Mesoblast back in the COVID treatment race?

After four months in the doldrums due to its COVID-19 treatment i...

AnteoTech launches 15-minute COVID-19 test in Europe

AnteoTech launches 15-minute COVID-19 test in Europe

Brisbane-based biotech firm AnteoTech (ASX: ADO) has officially l...

Brisbane biotech to trial "world-first" COVID-19 immunotherapy treatment

Brisbane biotech to trial "world-first" COVID-19 immunotherapy treatment

Brisbane and Seattle-based biotechnology company Implicit Bioscie...

Mayne Pharma breakthrough as FDA approves new contraceptive with plant-based estrogen

Mayne Pharma breakthrough as FDA approves new contraceptive with plant-based estrogen

A bet made by Mayne Pharma (ASX: MYX) in 2019 has paid off today ...

ECS Botanics plans major expansion of Tasmanian cannabis farm

ECS Botanics plans major expansion of Tasmanian cannabis farm

ECS Botanics (ASX: ECS) has submitted plans to the Office of Drug...

Creso Pharma appoints director of US business after New York legalises marijuana

Creso Pharma appoints director of US business after New York legalises marijuana

Australian medicinal cannabis company Creso Pharma (ASX: CPH) has...

Cynata COVID-19 treatment trial expanded to other respiratory illnesses

Cynata COVID-19 treatment trial expanded to other respiratory illnesses

Stem cell therapeutics company Cynata's (ASX: CYP) pool of el...

Starpharma to launch anti-COVID nasal spray with major UK pharmacy chain

Starpharma to launch anti-COVID nasal spray with major UK pharmacy chain

Pharmaceuticals manufacturer Starpharma (ASX: SPL) will commence ...

New US trial finds AstraZeneca vaccine 79 per cent effective

New US trial finds AstraZeneca vaccine 79 per cent effective

A Phase III trial of the AstraZeneca vaccine in the US has demons...

Openpay cracks into US and UK veterinary markets with ezyVet partnership

Openpay cracks into US and UK veterinary markets with ezyVet partnership

Buy-now pay-later (BNPL) operator Openpay (ASX: OPY) has announce...

IDT looks to manufacture COVID-19 vaccines on-shore

IDT looks to manufacture COVID-19 vaccines on-shore

Victorian pharmaceuticals manufacturer IDT Australia (ASX: IDT) h...

Advertisement

Partner Content

From capturing feedback early to providing messages with a higher r...
While it is common for businesses to haggle with suppliers over sma...
You may be familiar with traditional ways of earning passive income...
To help meet the rising demand for its construction and engineering...
By now, you’ve surely heard plenty about cryptoassets, their ...
After years of shrinking salaries, Australians began to wonder if t...
The City of Gold Coast (City) is supporting the delivery of an inno...
Beginning its life as a single store startup in Sydney’s tren...
'Digitisation' and 'digitalisation' are two words t...
With the ongoing supply chain crisis expected to continue throughou...
Advertisement